MDXG Q4 2019 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$76M-17.5% YoY

Gross Profit

$64M83.4% margin

Operating Income

-$5M-6.4% margin

Net Income

-$7M-9.8% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-14.0%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$167M

Total Liabilities

$133M

Stockholders' Equity

$34M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$93M	-17.5%
Gross Profit	$64M	$82M	-22.5%
Operating Income	-$5M	-$9M	+45.5%
Net Income	-$7M	-$36M	+79.4%